• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Idiopathic Pulmonary Fibrosis

home / clinical-spotlight / clinical-spotlight-idiopathic-pulmonary-fibrosis
Toby Maher, MD, PhD
November 28, 2025
Therapeutic Advances in IPF and PPF: Toby Maher, MD, PhD
New treatment options for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) could enhance patient care and monitoring.
Toby Maher, MD, PhD
November 26, 2025
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
The latest advancements in idiopathic pulmonary fibrosis (IPF) treatment offer promising efficacy and improved tolerability.
Toby Maher, MD, PhD
November 25, 2025
Challenges in Diagnosing, Treating IPF and PPF: Toby Maher, MD, PhD
Early diagnosis and treatment are crucial for managing idiopathic pulmonary fibrosis and progressive pulmonary fibrosis, yet barriers hinder timely intervention.
© 2025 MJH Life Sciences
AJMC®
All rights reserved.